Actualités

In the midst of all the discussion about whether the artificial intelligence boom is getting too pricey, Super Micro Computer (SMCI) just revealed a number that’s difficult to ignore. The AI server specialist expectsfiscal 2027 revenue of $65 billion to $72 billion, dramatically above the $52.5 ...

e.l.f. Beauty stock sits at an interesting crossroads right now. The intrinsic value estimate from a Discounted Cash Flow (DCF) approach points to the shares trading at a sizeable discount, while earnings-based valuation checks and a low value score suggest the stock is not obviously cheap. Over the past 5 years, e.l.f. Beauty has delivered a total return of about 212%, which puts current valuation front and center for anyone considering the stock today. Raised longer term revenue ambitions...

Recent commentary on Centene (CNC) has focused on a fresh debt redemption plan and higher expectations for revenue and earnings, which together are shaping how investors view the stock’s profitability potential. See our latest analysis for Centene. Centene’s share price has climbed strongly over 2026, with a year to date share price return of 58.07% and a 90 day move of 13.33%, while the 1 year total shareholder return of 145.23% suggests momentum has been building as investors respond to...

Microsoft stock spent most of 2026 in the penalty box. The AI spending looked too heavy. The returns were not yet visible. Then the company reported fourth-quarter results on July 29, and the stock jumped more than 27%. Azure crossed $100 billion. Copilot showed real adoption numbers. The narrative ...

BofA hikes Nebius price target to $310 on AI Growth

Merck stock has almost doubled investors' money over the past five years, yet there is a clear split between valuation tools. A Discounted Cash Flow (DCF) estimate points to a sizeable gap to intrinsic value, while market based multiples suggest the shares are already pricing in a lot of optimism. Merck has returned 99.7% over five years, which puts recent gains in focus as investors weigh how much future growth is already reflected in the price. Ongoing investment in oncology and new...

Microsoft stock gets a stunning price target hike on AI growth

Microsoft spent most of this year being punished for spending too much. The stock fell more than 20%. Analysts cut targets. The narrative shifted from AI winner to AI victim. Wells Fargo was part of that story. In mid-July, it trimmed its own target to $625 from $650, nervous about how much capital ...

Microsoft stock extends gains on a bullish JPMorgan research note. Here’s why the firm recommends buying MSFT shares at current levels.

CoreWeave's revenue has doubled for four straight quarters and its backlog dwarfs most competitors, yet the stock sits well below its peak. Whether the leverage and cash burn cancel out the growth story depends on one critical question our model tries to answer.

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday.

Nvidia and other tech stocks have a wide “dispersion” of price targets. Why that could be a problem for investors.

Cerebras Systems stock has climbed 28.1% over the past month, while a Discounted Cash Flow (DCF) intrinsic value estimate points to about 15.0% upside from the current market price, yet the company still scores poorly on broader valuation checks. That mix of strong recent gains, a supportive intrinsic value estimate and a low overall value score puts the current share price under closer scrutiny for investors thinking about the next move. Cerebras Systems is up 28.1% over the past month,...

Citi says Wix stock will rally in the second half of 2026. Here’s why the firm raised its price target on WIX shares today.

DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability, while FX and transition costs remain key tests.

Rocket Lab just posted a record quarter and a backlog that shocked Wall Street, but the CEO is selling shares while betting billions on a deal that could either transform the company or crush it. Here is what our model says the stock is actually worth.

These stocks have terrific track records for dividend growth, and they're likely to continue raising their payouts for the foreseeable future.

The reversal shows that investors still question whether extraordinary server and networking growth can support HPE's elevated expectations.

The analyst assigns half of Riot’s valuation to prospective site conversions, including a possible 756 MW critical IT deployment at Corsicana.

ALH's raised 2026 outlook boosts confidence, but fading pricing benefits will put more pressure on volume growth and margins.

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls

Investing.com -- In a note on Tuesday, Bernstein lifted its forecasts for wafer fabrication equipment (WFE) spending, raising price targets across its semiconductor equipment coverage on growing conviction that the current upcycle "has legs."

Bernstein Raises Microsoft Price Target to $660, Pushes Back on AI Spending Fears

Sandisk's wide-ranging price target overshadows the fact that most analysts rate the stock as a buy.

Faster production could reshape competition across AI memory

Apple downgraded, HPE upgraded: Wall Street's top analyst calls

Analyst Issues Bullish Microsoft Stock Call as AI Spending Pays Off

Stocks are getting a solid August boost. That has Wall Street altering their end of year price targets.

The communications-platform company's growth has now accelerated for two straight quarters -- and management raised the full-year guide to match.

Advanced Micro Devices just got a fresh vote of confidence from one of Wall Street's most accurate stock pickers, even as the chip giant's shares took a beating after earnings. JPMorgan analyst Harlan Sur raised his price target on AMD (AMD) to $550 from $385 recently, according to a research note ...